April 23, 2024 11:20 AM EDT
News Briefing

Brise rais­es $20M; Taro share­hold­er crit­i­cizes Sun Phar­ma deal

ENDPOINTS

Plus, news about Tar­sus Phar­ma­ceu­ti­cals and Bio­haven:

Brise Phar­ma­ceu­ti­cals rais­es $20M: The fund­ing comes from Shunxi Fund, Sher­pa Health­care Part­ners and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times